Creative Biolabs Upgrades Single-Cell Suite for Multi-Omics Research

Creative Biolabs, a biotechnology service provider based in Shirley, New York, has announced a significant upgrade to its single-cell analytical suite, designed to meet the growing demand for high-resolution cellular profiling. The enhanced platform offers end-to-end services, from single-cell transcriptome profiling to integrated multimodal and multi-omics workflows, supporting researchers in oncology, immunology, and neuroscience. As life science research shifts from bulk tissue analysis to single-cell resolution, the ability to dissect cellular heterogeneity has become critical for identifying rare cell subpopulations, characterizing tumor microenvironments, and tracing cell lineage trajectories. To address these needs, Creative Biolabs delivers robust, high-throughput single-cell RNA sequencing services that provide high sensitivity and coverage across thousands of individual cells, yielding detailed transcriptomic insights from fresh biological specimens.

Recognizing the challenges of processing complex or archival samples, the company also features specialized single-nucleus RNA sequencing (snRNA-seq) capabilities. For tissues prone to dissociation-induced damage or selective cell loss—such as human brain, myocardium, or flash-frozen biopsies—Creative Biolabs offers an optimized single-cell nuclei RNA sequencing service. By isolating intact nuclei, this method bypasses harsh enzymatic dissociation, minimizes artifacts, and retains informative nuclear RNA profiles, thereby expanding the scope of clinical translational research. Furthermore, the company advances a high-throughput single-cell multi-omics service that enables simultaneous interrogation of genomic variations, epigenomic landscapes, cell surface proteomics, and transcriptomes within identical cells. This integrated approach allows researchers to construct multi-dimensional cellular atlases and uncover novel therapeutic targets with unprecedented clarity.

A senior scientist at Creative Biolabs emphasized that understanding biology at single-cell and single-nucleus resolution is fundamental to precision medicine and biomarker discovery. The company's goal is to provide a seamless, modular analytical ecosystem that transforms difficult biological samples into reliable, high-dimensional datasets with rigorous bioinformatics support. Supported by advanced microfluidics, stringent quality control, and tailored bioinformatics pipelines, Creative Biolabs partners with academic and biopharmaceutical teams worldwide to unravel the complexities of human disease. For more information, visit https://singlecell.creative-biolabs.com/.